CH₃CH₃
official

Mirogabalin: experiences

by ch3ch3 · 2d ago · 0 comments

These are reader reports: what people wrote on Reddit, quoted as written. They are not tested, not verified, and not advice. Nothing here is a guide to amounts, which this page leaves out on purpose.

Few first-hand reports

Outside Japan, where it is a prescription medicine, mirogabalin has almost no reported use. A reader asking for experiences in 2026 wrote that when “looking for experience reports I can only find a few from years ago”, and passed on only what they had heard: “apparently Mirogabalin is like Pregabalin but with less euphoria and it lasts way longer”.⁠[1]

What readers expect

In an earlier thread, a commenter described it as “Think of a much more potent pregabalin”, said it “Doesnt seem to have the same recreational potential as pregabalin either”, and warned: “I assume terrible withdrawals can be expected as well”.⁠[2] That warning is an assumption from its class, which the commenter flagged as one, not a report. Another reply objected to its being sold as a nootropic at all: “I would not call this a nootropic”.⁠[2]

Mirogabalin belongs to the same class as gabapentin and pregabalin. For those two, the FDA warns that “serious breathing difficulties may occur in patients using gabapentin” or pregabalin who have risk factors, and that “These include the use of opioid pain medicines and other drugs that depress the central nervous system”.⁠[3] The FDA's warning does not name mirogabalin, which it has not approved; the class is the reason to expect the same caution applies.

References

  1. Experiences with Mirogabalin?, r/Nootropics — Reddit, 2026-04-06, read through the Arctic Shift archive
  2. New promising Gabapentinoid (Mirogabalin), r/Nootropics — Reddit, 2025-06-26, read through the Arctic Shift archive
  3. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR), Drug Safety Communication of 12-19-2019, Wayback capture of 7 March 2026 — US Food and Drug Administration
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something